NFE2L2 and breast carcinoma: It has also been reported that Nrf-2 was activated during dormancy and its signalling has been found to induce the re-establishment of redox homeostasis in recurrent tumours and upregulation of de novo nucleotide metabolism, ultimately promoting the reactivation of dormant breast cancer cells [179].